Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Robert Dunlap

Diagnostic Radiology Seattle, WA Medical Doctor

NPI 1982099727 CMS profile 10137434

747 Broadway, Suite Ww-739, Seattle, WA 98122

Open in the dashboard

General payments

$4,829

103 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Dunlap of Seattle, WA is reported in the CMS Open Payments database as having received $4,829 across 103 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $581 21
2024 General $1,039 27
2023 General $480 21
2022 General $1,190 17
2021 General $1,538 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Dunlap
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Robert Dunlap were reported at $581. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Robert Dunlap Diagnostic Radiology median Middle half National median
2019 $0 $108 $29–$318 $163
2020 $0 $65 $21–$252 $114
2021 $1,538 $92 $24–$292 $132
2022 $1,190 $104 $29–$294 $149
2023 $480 $110 $29–$337 $160
2024 $1,039 $113 $30–$356 $164
2025 $581 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Inari Medical, Inc. $1,670 34 payments
  2. Boston Scientific Corporation $587 11 payments
  3. AngioDynamics, Inc. $427 12 payments
  4. Bard Peripheral Vascular, Inc. $342 10 payments
  5. Sirtex Medical Inc $326 5 payments
  6. Medtronic, Inc. $316 8 payments
  7. Terumo Medical Corporation $277 6 payments
  8. Ethicon US, LLC $164 2 payments
  9. Penumbra, Inc. $148 1 payment
  10. Avanos Medical $142 1 payment
  11. Other $431 13 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,829 103 payments
Products named General payments · program years 2021–2025
  1. CT THROMBECTOMY SYSTEM KIT $1,670 34 payments
  2. FLOWTRIEVER CATHETER, S $1,670 34 payments
  3. SIR-Spheres Microspheres $326 5 payments
  4. AURYON LASER SYSTEM 100-120 VAC $293 9 payments
  5. TheraSphere Y90 Glass Microspheres 10 GBq $282 2 payments
  6. Azur CX Detachable $277 6 payments
  7. KYPHON Balloon Kyphoplasty $180 1 payment
  8. Trek $179 5 payments
  9. Neuwave $164 2 payments
  10. Penumbra System $148 1 payment
  11. Other $1,323 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Diagnostic Radiology: 24

Drug cost

$96

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Prednisone Generic 12 $96

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 255 billing codes

Paid by Medicare

$229,996

Medicare's payments for the services billed

Medicare patients

3,496

Average age 75

Services billed

6,565

2,025 women, 1,471 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Ischemic heart disease 36%
Diabetes 35%
Chronic kidney disease 33%
COPD 30%
Cancer 28%
Heart failure 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

103 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record